SSH - YOUNGSTOWN — History
CCN 362024 | 3-year financial timeline | COVID resilience: 0/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
-15.0%
Revenue CAGR (3yr)
5.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $29M | $20M | -33.1% | -15.0% |
| Operating Expenses | $22M | $24M | $18M | -22.2% | -8.8% |
| Operating Margin | 18.2% | 19.1% | 5.8% | -69.4% | -43.4% |
| Net Income | $5M | $6M | $1M | -79.5% | -51.9% |
| Licensed Beds | 61 | 55 | 42 | -23.6% | -17.0% |
| Total Patient Days | 15,425 | 15,410 | 10,504 | -31.8% | -17.5% |
| Medicare Day % | 44% | 39% | 36% | -7.3% | -9.4% |
| Medicaid Day % | 5% | 5% | 7% | +35.0% | +17.0% |
COVID Impact & Recovery
Resilience Score: 0/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -27.7% ($27M → $20M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-15.0%
This Hospital
+7.6%
State Avg
Latest Margin
5.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $16M | -0.3% |
| FY2024 (proj) | $12M | -6.5% |
| FY2025 (proj) | $8M | -12.7% |